TD Asset Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q2 | – | Sell |
-176
| Closed | -$443K | – | 1388 |
|
2017
Q1 | $443K | Buy |
176
+25
| +17% | +$62.9K | ﹤0.01% | 1241 |
|
2016
Q4 | $340K | Sell |
151
-47
| -24% | -$106K | ﹤0.01% | 1273 |
|
2016
Q3 | $495K | Buy |
+198
| New | +$495K | ﹤0.01% | 1187 |
|
2015
Q3 | – | Sell |
-85
| Closed | -$340K | – | 1394 |
|
2015
Q2 | $340K | Hold |
85
| – | – | ﹤0.01% | 1224 |
|
2015
Q1 | $339K | Buy |
85
+17
| +25% | +$67.8K | ﹤0.01% | 1212 |
|
2014
Q4 | $331K | Hold |
68
| – | – | ﹤0.01% | 1205 |
|
2014
Q3 | $274K | Hold |
68
| – | – | ﹤0.01% | 1178 |
|
2014
Q2 | $273K | Sell |
68
-8
| -11% | -$32.1K | ﹤0.01% | 1159 |
|
2014
Q1 | $345K | Buy |
76
+8
| +12% | +$36.3K | ﹤0.01% | 1123 |
|
2013
Q4 | $237K | Hold |
68
| – | – | ﹤0.01% | 1190 |
|
2013
Q3 | $278K | Buy |
68
+9
| +15% | +$36.8K | ﹤0.01% | 1132 |
|
2013
Q2 | $234K | Buy |
+59
| New | +$234K | ﹤0.01% | 1099 |
|